Rivernorth Capital Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30K Hold
250,000
﹤0.01% 453
2025
Q4
$70K Buy
250,000
+50,000
+25% +$16.4K ﹤0.01% 362
2025
Q3
$58K Buy
+200,000
New +$54.2K ﹤0.01% 364

Other funds holding TDACW

Rivernorth Capital Management's TDACW Position: Q1 2026 in Review

Rivernorth Capital Management held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 250,000 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

Rivernorth Capital Management first reported a position in TDACW in Q3 2025 and has held it in 3 quarters since. The position peaked at $70K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Rivernorth Capital Management held 250,000 shares of Translational Development Acquisition Corp Warrants worth $30K as of Q1 2026.
  • Rivernorth Capital Management left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Rivernorth Capital Management's portfolio in Q1 2026, its #453 holding.
  • Rivernorth Capital Management first reported a position in Translational Development Acquisition Corp Warrants in Q3 2025 and has held it in 3 quarters since.
  • Rivernorth Capital Management's Translational Development Acquisition Corp Warrants position peaked at $70K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Rivernorth Capital Management's 13F filing for Q1 2026, filed 15 May 2026.